New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Researchers compile detailed catalog of bacteria living in cancer metastases

Researchers compile detailed catalog of bacteria living in cancer metastases

byNetherlands Cancer InstituteCredit: CC0 Public DomainResearchers at the Netherlands Cancer Institute have compiled a detailed catalog of bacteria living in cancer metastases. Having analyzed o
Breakthroughs April 28,2024
Researchers compile detailed catalog of bacteria living in cancer metastases

Researchers compile detailed catalog of bacteria living in cancer metastases

byNetherlands Cancer InstituteCredit: CC0 Public DomainResearchers at the Netherlands Cancer Institute have compiled a detailed catalog of bacteria living in cancer metastases. Having analyzed o
Breakthroughs April 28,2024
New potential avenues for cancer therapies through RNA-binding proteins

New potential avenues for cancer therapies through RNA-binding proteins

byKing's College LondonGraphical abstract. Credit:iScience(2024). DOI: 10.1016/j.isci.2024.109288A new paper describes the role of two RNA-binding proteins in the development of
Breakthroughs April 28,2024
New potential avenues for cancer therapies through RNA-binding proteins

New potential avenues for cancer therapies through RNA-binding proteins

byKing's College LondonGraphical abstract. Credit:iScience(2024). DOI: 10.1016/j.isci.2024.109288A new paper describes the role of two RNA-binding proteins in the development of
Breakthroughs April 28,2024
Blood stem cells unlock clues for helping sepsis patients fight recurring infections

Blood stem cells unlock clues for helping sepsis patients fight recurring infections

Blood stem cells unlock clues for helping sepsis patients fight recurring infectionsby International Society for Stem Cell ResearchCredit: Pixabay/CC0 Public DomainSevere sepsis from bacterial or vira
Breakthroughs April 28,2024
Blood stem cells unlock clues for helping sepsis patients fight recurring infections

Blood stem cells unlock clues for helping sepsis patients fight recurring infections

Blood stem cells unlock clues for helping sepsis patients fight recurring infectionsby International Society for Stem Cell ResearchCredit: Pixabay/CC0 Public DomainSevere sepsis from bacterial or vira
Breakthroughs April 28,2024
Study of data from thousands of women suggests ovarian cycle is regulated by circadian rhythm

Study of data from thousands of women suggests ovarian cycle is regulated by circadian rhythm

by Bob Yirka , Medical XpressCredit: Puwadon Sang-ngern from PexelsA team of reproductive researchers affiliated with several institutions in France and the U.S. has found that the timing of monthly o
Breakthroughs April 28,2024
Study of data from thousands of women suggests ovarian cycle is regulated by circadian rhythm

Study of data from thousands of women suggests ovarian cycle is regulated by circadian rhythm

by Bob Yirka , Medical XpressCredit: Puwadon Sang-ngern from PexelsA team of reproductive researchers affiliated with several institutions in France and the U.S. has found that the timing of monthly o
Breakthroughs April 28,2024
First clinical trial of vosoritide for children with hypochondroplasia shows increased growth

First clinical trial of vosoritide for children with hypochondroplasia shows increased growth

byChildren's National HospitalStanding height SDS. Credit:eClinicalMedicine(2024). DOI: 10.1016/j.eclinm.2024.102591Vosoritide's first global Phase II study showed an average
Breakthroughs April 28,2024
First clinical trial of vosoritide for children with hypochondroplasia shows increased growth

First clinical trial of vosoritide for children with hypochondroplasia shows increased growth

byChildren's National HospitalStanding height SDS. Credit:eClinicalMedicine(2024). DOI: 10.1016/j.eclinm.2024.102591Vosoritide's first global Phase II study showed an average
Breakthroughs April 28,2024
Scientists say outdated diabetes drug still has something to offer

Scientists say outdated diabetes drug still has something to offer

byUniversity of California - San DiegoThis micrograph shows a single macrophage, which is a type of cell in the immune system. In obesity-related inflammation, large numbers of these cells infil
Breakthroughs April 28,2024
Scientists say outdated diabetes drug still has something to offer

Scientists say outdated diabetes drug still has something to offer

byUniversity of California - San DiegoThis micrograph shows a single macrophage, which is a type of cell in the immune system. In obesity-related inflammation, large numbers of these cells infil
Breakthroughs April 28,2024
Patients with device-detected atrial fibrillation and multiple comorbidities do not benefit from anticoagulation: Study

Patients with device-detected atrial fibrillation and multiple comorbidities do not benefit from anticoagulation: Study

by Angelika Leute, Kompetenznetz Vorhofflimmern e.V. (AFNET)Credit:European Heart Journal(2024). DOI: 10.1093/eurheartj/ehae225In patients with device-detected atrial fibrillation and a hi
Breakthroughs April 28,2024
Patients with device-detected atrial fibrillation and multiple comorbidities do not benefit from anticoagulation: Study

Patients with device-detected atrial fibrillation and multiple comorbidities do not benefit from anticoagulation: Study

by Angelika Leute, Kompetenznetz Vorhofflimmern e.V. (AFNET)Credit:European Heart Journal(2024). DOI: 10.1093/eurheartj/ehae225In patients with device-detected atrial fibrillation and a hi
Breakthroughs April 28,2024
Pharmacy researchers examine trends in rising cost of medicine

Pharmacy researchers examine trends in rising cost of medicine

by Laurie Fickman,University of HoustonCredit: Unsplash/CC0 Public DomainNewly published research from the University of Houston College of Pharmacy reveals an alarming trend in diabetic medicat
Breakthroughs April 28,2024
Pharmacy researchers examine trends in rising cost of medicine

Pharmacy researchers examine trends in rising cost of medicine

by Laurie Fickman,University of HoustonCredit: Unsplash/CC0 Public DomainNewly published research from the University of Houston College of Pharmacy reveals an alarming trend in diabetic medicat
Breakthroughs April 28,2024
Q&A: Can weight loss drugs help in addiction treatment?

Q&A: Can weight loss drugs help in addiction treatment?

by Christine Yu,Pennsylvania State UniversityCredit: Penn State /Creative CommonsIn recent years, the popularity of drugs like Ozempic and Wegovy has skyrocketed. While this new class of d
Q & A April 28,2024
Q&A: Can weight loss drugs help in addiction treatment?

Q&A: Can weight loss drugs help in addiction treatment?

by Christine Yu,Pennsylvania State UniversityCredit: Penn State /Creative CommonsIn recent years, the popularity of drugs like Ozempic and Wegovy has skyrocketed. While this new class of d
Q & A April 28,2024
Understaffed nursing homes more likely to overuse antipsychotics as 'chemical restraints,' study finds

Understaffed nursing homes more likely to overuse antipsychotics as 'chemical restraints,' study finds

byNew York UniversityCredit: Pixabay/CC0 Public DomainNursing homes in disadvantaged communities are more likely to overmedicate residents with antipsychotics, especially homes that are understa
Breakthroughs April 28,2024
Understaffed nursing homes more likely to overuse antipsychotics as 'chemical restraints,' study finds

Understaffed nursing homes more likely to overuse antipsychotics as 'chemical restraints,' study finds

byNew York UniversityCredit: Pixabay/CC0 Public DomainNursing homes in disadvantaged communities are more likely to overmedicate residents with antipsychotics, especially homes that are understa
Breakthroughs April 28,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com